ATHE — Alterity Therapeutics Ltd

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ATHE Bullish with a Setup Score of 37, net conviction 38, actionability 36. How the Setup Score works →

Total Setup Score37
Directional BiasBullish
Net Conviction38
Actionability36 (in range)

Key signals behind this score

About Alterity Therapeutics Ltd

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy ea… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$3.12
Market Cap$55.9M
Float14.4M
Shares Outstanding18.2M
Price/Sales (TTM)15.48
vs. Analyst Target+324.7% to analyst PT
Operating Margin (TTM)-1816.16%
Revenue (TTM)$3.6M
Dividend RateNone
Analyst Target Price$13.25 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2021 $4.3M -$15.3M $4.0M -$15.2M
2022 $5.1M -$12.8M $4.8M -$17.4M
2023 $3.9M -$13.8M $3.6M -$14.6M
2024 $4.0M -$19.1M $3.8M -$19.6M
2025 $5.4M -$12.1M $5.3M -$14.6M
2026 N/A -$22.9M -$113,010 -$27.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Dec 2024 $1.6M -$7.2M
Jun 2025 $3.8M -$5.0M
Dec 2025 N/A -$9.4M
Jun 2026 N/A -$14.0M

Ownership & Float

Institutional Ownership2.1%
Short Float0.2%
% of All Funds Holding0.25%
Number of Funds Holding22

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$4.12Near-term / short-term trend
Weekly40-Week SMA$4.06Medium-term trend
Weekly80-Week SMA$4.13Cyclical trend (business cycle)
Weekly200-Week SMA$3.15Secular trend (multi-year)
Monthly10-Month SMA$3.98Near-term monthly trend
Monthly20-Month SMA$4.00Medium-term monthly trend
Monthly40-Month SMA$3.13Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.50 support 1.94x 21 months ago
$1.20 support 1.16x 22 months ago

Historical Earnings Reactions (53 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.01% 0.00% 47.17% 7.63% -6.67%
1 Day 0.37% 0.00% 45.28% 26.20% -10.64%
1 Week 0.49% 0.69% 52.83% 20.48% -28.76%
2 Weeks -0.75% -2.55% 37.74% 31.96% -28.54%
1 Month -2.34% -3.23% 37.74% 68.28% -75.07%

Next earnings: August 27, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan9.8%60.9%23
Feb-5.5%39.1%23
Mar0.8%43.5%23
Apr0.4%56.5%23
May-4.4%39.1%23
Jun3.0%30.4%23
Jul8.5%52.2%23
Aug5.6%56.5%23
Sep-5.0%26.1%23
Oct-6.1%34.8%23
Nov-2.0%43.5%23
Dec3.5%30.4%23

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.32% 41.8% 1085
Tuesday -0.03% 39.4% 1190
Wednesday 0.14% 41.0% 1190
Thursday 0.13% 40.3% 1165
Friday 0.06% 42.8% 1160

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 2.1%

Insider Transactions — Smart Summary

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change47,620
% of Float0.3%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Marks Peter Ashley +$23,810 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-09-08 Marks Peter Ashley +$23,810 Transaction at $0.50, now +524.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Alterity Therapeutics Ltd (ATHE) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ATHE on Trend Edge →